Search
Defining SOCS1 haploinsufficiency in Human – SOCSIMMUNITY
Tumor genetic mapping has changed the way to cure cancers. Similar revolution is now ongoing in autoimmune diseases, as shown in recent identification of monogenic causes of autoimmunité. Cytokines are essential effectors of immune responses and signal through the JAK-STAT pathway. Inducible su
FUNGAL IMMUNE SENSITIZATION: A DIAGNOSTIC HUB FOR FUNGAL EXPOSOME, INDIVIDUAL SUSCEPTIBILITY AND LONG-TERM LUNG FUNCTION AND HEALTH – FUNGIPLEX
HYPOTHESIS Multiplexed analysis of the diversity and targets of fungal exposome-induced sensitization enables risk modeling and long-term prediction, at the population and individual levels, of lung function, a correlate of longevity and quality of life. OBJECTIVES Main objective: To establi
Targeting exogenous NaV1.1 activity to inhibitory neurons in Dravet syndrome mice – DSynchro
Dravet syndrome (DS) is a severe childhood epilepsy caused by haploinsufficiency of SCN1A. SCN1A encodes NaV1.1, the alpha subunit of a type I voltage-gated sodium channel. A significant decrease in NaV1.1 activity generates an imbalance between brain excitation and inhibition that causes DS comorbi
Combination of proton radiations and oncolytic viruses to eradicate cancer – PROTOVEC
The fight against glioblastoma (GBM) and pancreatic ductal adenocarcinoma (PDAC) urgently requires the development of novel and more efficacious tools to combat these deadly malignancies. This is clearly evidenced by a dismal 5-year survival rate of only 5-10 % for patients suffering from either dis
Peripheral T cell immunity in Tauopathies: role in the pathophysiology and therapeutic modalities – PeriTimmTau
Involvement of immunity in neurodegenerative disorders is a strongly emerging field, now considered a most promising avenue for the development of innovative treatments and immune biomarkers of clinical interest. Strong evidence support that innate neuroinflammation mediated by microglia and astrocy
Analysis of Genotype-phenotype correlation in Intellectual Disability for improving diagnosis and proposing personalized medicine: PAK3 example – IDGePhe-PAK
Mutations in genes belonging to the RHO GTPase pathway are responsible for intellectual disability (ID), psychiatric disorders and brain development anomalies. The great heterogeneity of phenotypes associated with these gene mutations renders the development of therapeutic strategies strenuous. Stud
At the origins of anemia and thrombocytopenia in Fanconi anemia. – FANCDIFF
Fanconi anemia (FA) is a rare bone marrow failure (BMF) syndrome presenting defects in hematopoietic stem and progenitor cells (HSPCs), anemia, thrombocytopenia and increased risk to progress towards myelodysplasia and acute myeloid leukemia. Even if BMF in FA is thought to be a direct consequenc
Target-agnostic drug discovery approaches for neuromuscular diseases – TREAD
Neuromuscular diseases correspond to a vast group of disorders that collectively affect 160 per 100,000 people worldwide. Despite recent progresses, a large proportion of these diseases still do not have definitive treatments. Progresses towards identification of new treatments have been hampered by
From leukocyte migration dysfunction to phenotypic drug discovery in Ataxia Telangiectasia – MOTILE-AT
Ataxia Telangiectasia (AT) is an incurable inherited disorder arising from bi-allelic mutations in the ATM kinase. Clinically, AT presents as an immune deficiency (ID) with high cancer incidence. ATM has almost thousand predicted targets, which have delayed the identification of cellular mechanisms
Dissecting the immunogenotypic basis of type I InterFeroNs-driven PSOriasis – DIFN-PSO
We recently identified by investigating a Mendelian psoriasis model a new mutatioon of a gene encoding a protein involved in skin immune responses, which leads to a constitutive activation of the related signaling pathway. By gathering a consortium with high level complementary expertises, we plan n
Therapeutic SMall HSPs Inhibitors: from Acute Respiratory disTress syndrome To PROGRESSive lung fibrosis – SMART-PROGRESS
Among diffuse interstitial lung diseases (ILDs) many pathologies including Idiopathic Pulmonary Fibrosis (IPF) and ILDs related to connective tissues (i.e. rheumatoid arthritis-ILD, systemic sclerosis-ILD) are associated with progressive fibrosis. Beyond them, lung fibrosis is also a complication of
Post-translational modifications of apolipoproteins in diabetes and cardiovascular risk prediction – POTOMAC
Type 2 diabetes is a major health burden worldwide. The disease is primarily characterized by chronic hyperglycemia and lipoprotein metabolism disorders, reducing both the quality of life and life expectancy, especially by promoting cardiovascular complications. Therefore, patients with type 2 diabe
Effects of intravascular administration of mesenchymal stromal cells derived from Wharton’s Jelly of the umbilical cord on systemic immunomodulation and neuroinflammation after traumatic brain injury. – TRAUMACELL
No treatment for traumatic brain injury (TBI) patients has yet provided prolonged neurorestorative effects. Sustained TBI-induced neuroinflammation (NI) is associated with poor outcomes and a growing body of evidence suggests a link between NI and post-TBI neurodegenerative disorders (ND). Thus, mod
Exploiting tear film resources to fight corneal pathologies – TeFiCoPa
The cornea, transparent tissue protecting the eye, is instrumental to a clear vision. It is composed of a stratified epithelium supported by a mesenchymal stroma. While the stroma is mainly acellular, the epithelium forms the barrier protecting the eye chamber. This epithelial compartment undergoes
Demystifying and treating spasticity after spinal cord injury – SpasT-SCI-T
Spasticity may develop months after a spinal cord injury with no satisfactory cure. Spasticity mainly manifests by hypertonia and results in part from a hyperexcitability of motoneurons. We showed that calpains (proteases) foster the hyperexcitability of motoneurons by cleaving Na+ channels and KCC2
New therapeutics strategy against preeclampsia: Angiogenic switch to Physiological state by Extracorporeal Removal of sFLT-1 and release of PlGF – APHERESE2
Preeclampsia is a hypertensive disorder of pregnancy associated with important maternal and perinatal mortality. It complicates 2 to 7% of pregnancies and causes more than 70 000 maternal deaths each year worldwide. Although symptomatic management has improved there is currently no curative treatmen
HERV-based immunotherapy development for colorectal cancer treatment – HERIC
The potential of immunotherapy to achieve durable responses in some MSI-H colorectal cancers (CRC) has been recognized. However, the need for biomarkers that could predict immune checkpoint inhibitors response became apparent. Beyond MSI-H CRC, the critical challenge is to develop strategies for tar
Oxygen metabolism by MRI in clinical stroke: An innovative biomarker in cerebrovascular diseases – CMRO2
Stroke is a devastating disease. For ischemic stroke, recent advances with endovascular thrombectomy (EVT) enable revascularization of the occluded artery in a fast and efficient way. Despite this revolutionary intervention and successful recanalization, over half of patients remain disabled. Curren
Predictive and personalized medicine of pancreatic cancer – CancerProfile
The CancerProfile multidisciplinary project brings together highly complementary translational research institutes to develop a novel standard of patient stratification for predictive and personalized medicine of pancreatic adenocarcinoma cancer. The overall objective is to fully integrate cutting-e
PPARgamma Repression Of Tubular Epithelial Cell dysmetabolism to Treat Fibrosis – PROTECT-FI
The PROTECT-Fi project will be conducted in a non-investigated field regarding treatment innovation. The study is based on our original observations: 1/ A key transcription factor, PPARG, that regulates metabolism in renal tubular epithelial cells (TECs) is lost, particularly in mice and pat
In vitro maintenance of FOXP3+Treg cells phenotype, epigenetics and function stability in humans – MAINTREG
FOXP3 expressing regulatory CD4+ T (Treg) cells are instrumental for the maintenance of self-tolerance. Treg cell therapy has a promising potential for the treatment of autoimmune diseases or for the induction of operational tolerance in solid organ transplantation. However human Treg cells are unst
Role of the Amphiregulin-EGFR axis in the modulation of capillary leakage during acute circulatory failure – Areg-Shock
Circulatory shocks (20,000/year in France, 40% mortality) are a major public health issue. Vascular permeability during shocks affects macro and micro-circulation, and correlates independently with mortality in septic and cardiogenic shock. However, determinants of vascular leakage are poorly unders
Specific platelet targeting of serpinE2 for haemophilia treatment – PERSIA
Hemophilia A and B are inherited bleeding disorders that result in impaired thrombin generation. Correction of bleeding in hemophilia patients is best achieved by the therapeutic administration of factor VIII (FVIII) or factor IX (FIX), the respective missing coagulation factors. Replacement therapy
Molecular signatures of esophageal atresia: towards the identification of the molecular causes of the different forms of esophageal atresia and prenatal diagnosis – OESOMICS
Esophageal Atresia (EA) is a rare developmental defect of the foregut that presents with or without a Tracheo-Esophageal Fistula (TEF). The prevalence of EA/TEF over time and around the world has been relatively stable (> 165 new EA/year on average in France). EA/TEF is manifested in a broad spectr
Precision medicine in Alzheimer’s Disease: integration of resilience metrics and risk factors – AD-resilience
A promising path for developing precision medicine in age-related diseases is to take into account the role of disease resistance mechanisms (resilience) in addition to that of disease drivers and risk factors. AD-resilience will accelerate the development of precision medicine for patients that fac
Role of IRE1-XBP1 activation in Natural Killer cells during chronic vascular rejection of solid organ transplants – ROCKI
End-stage vital organ failure is a life-threatening condition and the leading cause of premature death worldwide. Economic burden of vital organ failure is currently estimated 25% of total health expenditures, in rapid expansion. Patients with end-stage vital organ failure depend on solid organ tra
Social Information pRocessing in Children: an ocUlo-pupillometric tool for Standard evaluation – SIRCUS
Autism spectrum disorder (ASD) as well as other neurodevelopmental disorders (NDD) are a public health priority in France. To help early diagnosis and improve therapeutic care for children, the French government has just set up an early detection program with the creation of «NDD platforms«. Thanks
An innovative non-mutant neoepitopes-based immunotherapy targeting immune-escaped tumors – NEOCOMBO
Although promising, immunotherapies targeting PD-1 are effective in only a fraction of cancer patients and the mechanisms associated with resistance are poorly elucidated. Indeed, tumors use additional pathways to evade CD8 T-cell recognition in particular alterations in peptide transporters TAP. We
Effects of intracranial electrical brain stimulation on neuronal dynamics recorded by tetrodes microelectrodes in epileptic patients – DYNEUMICS
Intracranial electrical brain stimulations (EBS) are used during stereoelectroencephalography (SEEG) in pharmacoresistant epilepsy to delineate the epileptogenic zone by triggering seizures and other electrophysiological changes, and to do functional mapping before a surgery that may make patients
Validation of Behavioral Sensitization as a therapeutic Target in Crack-cocaine dependence – CRACK-TARGET
Context: Paris region and the French west indies face a specific epidemic of crack-cocaine use, mostly by socially deprived subjects, highly visible in open drug scenes, with little access to the care system. Patients who suffer from crack-cocaine dependence experiment a high rate of medical compl
Exploiting autophagy-lysosomal dysfunction of immune cells as therapeutic target in periodontal diseases – TopGum
Periodontal diseases are inflammatory diseases of infectious origin. They are characterized by the destruction of tooth-supporting tissues and lead to tooth loss. The prevalence of periodontitis is high as such disease is found in more than 50% of the population worldwide with more than 10% presenti
Dysregulation of Type I interferon signalling in Juvenile Dermatomyositis: from pathophysiology to new biomarkers. – JDMINF2
Juvenile dermatomyositis (JDM) is a rare and severe idiopathic inflammatory myopathy that begins in childhood. JDM is associated with significant morbidity and mortality and although recent immunomodulating therapies have improved outcome, 40-60% of patients present with relapsing or chronic disease
Endothelial therapy for ischemic stroke. – ETHERISCH
Ischemic stroke is a major cause of death and morbidity worldwide and therefore an important public health issue. Current treatment, limited to removal of the large vessel occlusion at origin of ischemia, is offered to a minority of patients and not always effective. Novel adjunct therapies are ther
Kidney Injury: PYRophosphate, an INhibitor of Arterial calcifications – KI-PYRINA
Patients affected by chronic kidney disease (CKD) and on hemodialysis are dramatically affected by cardiovascular mortality, due to vascular calcifications. Some studies suggest that pyrophosphate (PPi) deficiency, a potent calcification inhibitor, could be involved in the development of arterial ca
Black-blood Magnetic Resonance Imaging and Automated AI-based Segmentation for Highly Detailed Characterization of Myocardial Scar – HEARTFACT
Cardiovascular diseases cause more than a third of all deaths in Europe. Late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) plays a central role in the management of patients with structural heart diseases by providing high contrast between the injured and healthy myocardium. Unfortuna
Gene therapies approaches for Charcot-Marie-Tooth diseases: targeting the right cell type and compartment – GENERATE
Charcot-Marie-Tooth disease (CMT) is a rare and incurable disease of the peripheral nervous system. CMTs are defined according to the cell type affected: either the Schwann Cell (SC) in demyelinating CMT, or motor (MNs) and sensory neurons (SNs) in axonal CMT. More than 100 causative CMT-related gen
New Imaging and GABA Spectroscopy Modalities to Localize the Epileptic Zone – EPI-CATCHER
In drug-resistant epileptic patients who may benefit from a surgical resection, a poor localization of the epileptic zone (EZ) may lead to neurological sequelae. We have recently developed two new approaches to identify the EZ in a mouse model of focal epilepsy: the first is based on GABA NMR spectr
Lipocalin-2 as a novel therapeutic target for retinopathy of prematurity – EliotROP
Retinopathy of prematurity (ROP; ORPHA:90050) remains the major ocular disorder of the neonate and the dominant cause of severe visual impairment in childhood in Europe and North America, but also in middle-income countries. It is a multi-factorial disease of retinal development in which hyperoxia,
Phenotype-genotype association and identifying treatment strategies for COQ8A-ataxia, a rare recessive ataxia linked to CoQ10 deficiency (TREATCOQ) – TREATCOQ
COQ8A-ataxia is a rare mitochondrial disorder characterized by slowly progressive cerebellar ataxia, combined with variable features including developmental delay, cognitive impairment, epilepsy, dystonia and myopathic features. This rare ataxia is due to loss of function mutations in COQ8A, with no
TAGLN3 as a new regulator of neuroinflammation: from a biomarker to a biotarget in Alzheimer’s disease – TRANS3
Alzheimer's disease (AD) is a neurodegenerative disease remaining incurable yet. AD is a progressive disease with a silent phase for many years before the first symptoms of dementia. Identifying an early biomarker could pave the way for the identification of new therapeutic windows and / or the deve
Systematic assessment of MEFV coding sequence variants pathogenicity-A new methodology applied to two autoinflammatory diseases – SolvingMEFVariants
Monogenic diseases are due to mutations that affect 7,000 different genes. One major roadblock in the diagnosis of rare diseases is the number of gene variants of uncertain significance. Novel methodologies need to be developed specifically to determine the pathogenicity of variants in the coding se
Insights into the mode of action of flunarizine on microRNAs and/or targets n rare motor neurondiseases – MiRrOR
Amyotrophic lateral sclerosis (ALS) and Spinal muscular atrophy (SMA) are rare neurodegenerative diseases characterized by a progressive loss of motor neurons. A marked improvement of SMA patients is observed with recent innovative therapies, but the clinical outcomes are unpredictable and might sho
Characterization of the mechanisms responsible for Artificial Kidney-Induced Kidney injury after acute kidney failure in intensive care units – MAKIKI
The repetition of acute kidney injury (AKI) episodes is recognized as a major risk factor for chronic kidney disease (CKD). It is therefore crucial for the long-term quality of life of the patients to limit the incidence of AKI and to improve renal function recovery. Renal replacement therapy (RRT)
Analysis of the interplay between digestive microbiota and immune system in the development of rheumatoid arthritis – BactRiA
Background: Recent investigations have suggested a mucosal origin of rheumatoid arthritis (RA) because of its remarkable association with several mucosal inflammatory conditions. These findings are consistent with the hypothesis of a cross-reaction between auto-immune antibodies directed at both mic
KREMEN2, an inhibitor of NF-kB-mediated auto-inflammation involved in human genetic disease – KREM-AIF
We recently identified a homozygous private mutation targeting the KREMEN2 gene in a multiple consanguineous family with autoinflammatory disease (AID) of unknown aetiology. Two members of the family were strongly affected, in particular a systemic inflammation associated with severe skin manifestat
Zebrafish: a model to test the therapeutic potential of epidrugs on complex Kabuki phenotypes – ZEPIKAB
Kabuki syndrome (KS) is a rare genetic disorder primarily related to mutations of KMT2D (histone-lysine N-methyltransferase 2D), a gene encoding an enzyme which catalyzes the methylation of lysine 4 on histone H3 (H3K4) and regulates gene expression in different biological contexts. KS individuals d
Carborane based vitamin D analogs for the treatment of rare disorder induced by hypervitaminosis D – CarBAV
The bioactive vitamin D (1,25D3) is a key regulator of calcium homeostasis. High circulating levels of vitamin D (calcitriosis) lead to hypercalcemia, and are a hallmark of several rare refractory pediatric disorders including idiopathic infantile hypercalcemia type I (IIH1). IIH1 is induced by loss
Developing a SHERLOCK platform for multipurpose detection of trypanosomatid Parasites. – SherPa
Neglected tropical diseases caused by vector-born trypanosomatids - African trypanosomiases, Chagas disease and leishmaniases - affect both humans and animals, and disproportionately levy an economic burden on those living in poverty. Progression towards their control or elimination is dependent on
Functional prosthesis for the repair of congenital diaphragmatic hernia with large defect – DIAPID
Giant congenital diaphragmatic hernia is a rare congenital malformation with a high morbidity and mortality rate even today despite the fabulous progress of neonatal resuscitation and antenatal follow-up. These advances have made possible to bring increasingly severe forms of hernia to surgery, requ
Innovative Neuroprotective Strategy Based on a New Class of Purine Derivatives for Neonatal Ischemic Encephalopathy – INSPIE
Hypoxia-ischemia (HI) is one of the leading causes of neurodevelopmental morbidities in infants. There are no pharmacological treatments. HI brain injury is characterized by inflammatory response along with alterations in the blood-brain barrier (BBB), both triggering neuronal damage. INSPIE project
Interferon-mediated impairment of myogenic epigenetic regulation in inflammatory myopathies – IFN-Epi-IM
Idiopathic Inflammatory myopathies (IMs) exhibit a strong Interferon (IFN) signature correlated with the disease severity. Although most patients have muscle defects that resist to treatments, myogenesis has been overlooked. Our data show that: a) IM-derived muscle stem cells (MuSCs, which sustain m
INFLAMMATION AND BLOOD BRAIN BARRIER INTEGRITY AS BIOMARKERS OF SUICIDAL BEHAVIOR. – IBBBIS
The prevention of suicidal behaviors (SB) is a major public health priority worldwide, especially since the phenomenon is feared to worsen in the context of the COVID 19 pandemic. The identification of hig-risk subjects remains a major challenge for clinicians as they currently assess only clinical
Targeting cellular MEchanisms of altered regeneration for ALcoholic hepatitis precision medicine. – MEdicAL
Alcoholic hepatitis (AH) is the most severe form of alcohol-associated liver disease (ALD). The pathogenesis of this life-threatening disease is complex and poorly understood due to the lack of animal models, while translational studies suffer from limited access to human liver samples. Despite its
Combining molecular and functional genetics to decipher pathophysiological mechanisms in oculocutaneous albinism. – OCAGEN
Albinism is a rare disease associating generalized hypopigmentation and severe visual deficits in patients. Currently, the link between altered pigmentation and the retinal development anomalies that lead to impaired vision remain poorly understood. Albinism comprises a group of clinically and genet
Pathways and moleculaR analysEs to Derive multi-omIC signatures predictive to response to Treatment in JIA – PREDICT-JIA
Juvenile Idiopathic Arthritis (JIA) is an heterogeneous group of inflammatory arthritis, that cripples pediatric patients, with very little information available on the potential genetic contribution, in pathophysiology and variable responses rates to available therapies. Thus, overall, JIA has very
Models of AL amyloidosis for a better understanding of the disease and therapeutic investigations – ModAL
AL amyloidosis is a rare but devastating disease caused by the tissue/organ deposition of amyloid fibrils composed of a monoclonal immunoglobulin light chain (LC). Despite extensive biochemical studies and clinical investigations, the pathophysiology of this disease is still misunderstood due to the
Exploring fungal cell-wall polysaccharides for immunotherapies – FUNPOLYVAC
Annually, Invasive Fungal Infections (IFIs) kill over 1.6 million people globally, a number equal to the mortality due to tuberculosis and greater than the death caused by malaria. Despite the available antifungal drugs, the mortality associated with IFIs remains high due to host-related factors as
Impact of S. aureus on the outcome of chronic lung infections in cystic fibrosis – ChronoSTA
Cystic fibrosis (CF) is the most frequent severe recessive disorder in European populations. In France, Staphylococcus aureus (Sa) dominates the lung microbiota of CF children and is able to persist for years in the lung. To date, the exact contribution of Sa to the decline of respiratory function i
Building of a diagnostic/prognostic database by high-throughput multiplexed assays for human ERG variant effects – CarDiag
Channelopathies induce severe heart rhythm or conduction disorders. Mutations of the KCNH2 gene, that encodes the human (h) ERG channel, is responsible for 30% of all cases of long QT syndrome. Besides, hERG is frequently responsible for off-target effects of several pharmacological agents. With the
genotype/phenotype correlations to alloW rupturE risk stratification of intraCranial Aneurysm – WECAN
Intracranial aneurysms (IAs) affect 3% of the population and IA rupture is a devastating event (40% mortality). The ICAN biobank includes 3400 IA patients with clinical, imaging and DNA. WECAN relies on this exceptional resources for rupture risk stratification among IAs. WP1 uses image processing t
Evaluation of the importance of oligogenic inheritance in male infertility – OLIGO-SPERM
We plan to generate multi-mutant mice carrying up to five heterozygous mutations in different genes involved in sperm production to identify the structural and functional sperm defects induced by these cumulated mutations. We will then compare the mutational burden in genes associated with infertili
Translational investigation of Neurodevelopmental Disorders caused by impairment of the Ubiquitin-Proteasome System – UPS-NDDecipher
The ubiquitin-proteasome system (UPS) is one of the major eukaryotic pathways for intracellular degradation of proteins which are misfolded, oxidized, damaged and/or no longer needed. Denatured proteins to be degraded are specifically tagged with ubiquitin chains before being addressed to the 26S pr
Unveiling the population dynamics of the filarial worm Loa loa using population genetics – LoaGen
Loiasis is a vector-borne parasitic disease caused by the worm Loa loa and transmitted from human to human through the bites of Chrysops. This disease is a public health concern for about 20 million people living in forested areas of central Africa. In 2016, we demonstrated that high grade infection
Development of an instrumented hammer for the estimation of the stability of implants used in orthopedic surgery – OrthoMat
Total hip replacement (THR) surgery is the second most common surgery in France with a total number of around 150,000 patients per year. However, there remain risks of failure which may have dramatic consequences and which depend on the implant primary stability. An increasing number of THR is perfo
Understanding the pathophysiology of pain in Parkinson’s disease – PDPAIN
Pain in Parkinson’s disease (PD) is one of the non-motor symptoms contributing to impaired quality of life of patients. Among the different types of pain observed in PD, central pain has the highest severityand appears to be more difficult to treat than the nociceptive pain. A better knowledge of th
Modulating activity of the necroptosis pathway to rescue steatotic liver grafts – DELFAT
Liver transplantation is the only therapeutic option for patients with end-stage liver disease. However, the rising prevalence of chronic liver diseases, such as non-alcoholic fatty liver disease (NAFLD), has increased the number of patients requiring liver transplantation, and the duration on waiti
Preclinical Evaluation of Completely Biological Monocusp Valve and Transannular Patch for the Fallot’s Tetralogy Correction – BIOVALVE
Fallot's tetralogy is the most common cyanotic heart malformation in newborns. It can be corrected by surgical management which consists in enlarging the right ventricular outflow tract. This approach generates pulmonary valve leakage that must be repair. Synthetic or chemically-treated biological p